A股異動丨協鑫集成(002506.SZ)低開4.64% 控股股東及泗陽經開區實業終止實施增持計劃
格隆匯9月10日丨協鑫集成(002506.SZ)低開4.64%,報3.7元,總市值188億元。協鑫集成昨晚公告稱,公司於近期收到公司控股股東協鑫集團有限公司(簡稱“協鑫集團”)及江蘇泗陽經濟開發區實業有限公司(簡稱“泗陽經開區實業”)提交的《關於終止實施增持計劃的告知函》,並於2020年9月9日召開董事會,審議通過了相關議案。此前,協鑫集團及泗陽經開區實業推出了原定金額不低於5億元、不高於10億元的增持計劃。截至本次公告披露日,協鑫集團及泗陽經開區實業未增持公司股份。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.